Endocrinology

In visits with overweight or obese children with high blood pressure, pediatricians either provide no communication about BP or unclear or dismissive statements, unless SBP is ≥120 mmHg.

Find out what you know about the facts and some emerging evidence.

The new score was developed by incorporating a weighted score into 6 clinical facgtors associated with AGHD.

Patients with diabetic macular edema (DME) switching to aflibercept from ranibizumab improved their BCDA by an average of 5 letters over 9-12 months.

Ronald Gentile, MD, and colleagues investigated pain-reduction strategies following intravitreal injections. The results have implications for patient experience, physician ratings, and treatment adherence.

Sample: Under which circumstances do the recent USPSTF guidelines recommend screening for thyroid dysfunction? 

An anti-PIGF, a plasma kallikrein inhibitor, and a pan RGD integrin antagonist are some of the investigational treatments in the pipeline for diabetic retinopathy and diabetic macular edema.

David Brown, a retina specialist discusses how retina and diabetes specialists can coordinate care and education for their patients as well as the outlook for AMD/DME research.

In a phase 2 study, a long-acting, implantable delivery system for ranibizumab allowed patients with wet age-related macular degeneration to go up to 15 months before requiring a refill.

My partner is leaving in December. She asked me not to be angry; not to hate her. I said I couldn't and wouldn't -- but to ask me again in January.

Which common treatment method for hyperthyroidism will lower a patient's risk for cardiovascular disease? Authors of a new study sought to find out.

New data suggest hepatitis C infection, but not hepatitis B infection, increases the prevalence of diabetes in patients who undergo kidney transplants.

A patient may resist the move to insulin in the face of even irrefutable evidence that it's time. A GLP-1 RA is often moe attractive. Why? Also, why not?

TRIM-AGHD was found in this study to be highly responsive to patient-reported response to treatment in adults naïve to GH therapy.

The once-weekly novel growth hormone derivative was favored over once-daily hGH in this head-to-head trial that evaluated treatment satisfaction.

A new study suggests it may be time to scrutinize the efficacy of the longstanding standard of care for hypothyroidism.

Can albiglutide reduce the risk of cardiovascular events in T2DM patients? A new study sheds some light. 

The IMPLANT 2 trial of nolasiban showed a significant increase in the rates of ultrasound-confirmed pregnancy at 10 weeks as well as live births.

Tumor size does indeed matter in the recurrence rate of papillary thyroid carcinoma, according to a new study.

A comparative study found that online prevention programs are just as effective and have higher participation rates compared to in-person programs.

A new study has found that the link between subclinical hypothyroidism and metabolic syndrome is only present in type 2 diabetes.

Lucia Novak discusses the importance of testing for cardiovascular outcomes of diabetes treatments and compares the cardiovascular effects of several diabetes drugs.

Lucia Novak, a diabetes care specialist, discusses some of the gaps that remain in diabetes management and what providers can do to help bridge those.

Low serum estradiol found to have a causal effect on bone mineral density and fracture risk in men vs low testosterone, according to a new study.

The FDA has been granting priority review to more pipeline drugs without skimping on application standards. What makes up a viable novel therapy application, specialty by specialty?